Dolomite Bio, a leading provider of cutting-edge single cell technologies, today announced the launch of a new?scRNA-Seq Reagent Kit to expand the Nadia Instrument portfolio. This convenient and cost-effective option is being showcased at the Advances in Genome Biology and Technology 2019 General Meeting (AGBT2019) – February 27th?to March 2nd?in Marco Island, Florida.
After careful consideration, Dolomite Bio have decided to discontinue the manufacture and sales of the scRNA-Seq modular system. Dolomite Bio will be accepting orders of the scRNA-Seq modular system up until 30th June 2019 and will supply parts to current users until 30th June 2024.
Dolomite Bio, part of the Blacktrace group, is helping to drive forward the single cell genomics revolution. Single cell analysis promises to transform drug discovery and disease research, enabling scientists to investigate cell diversity and quantify gene expression at the cellular level.?
Dolomite Bio, a leading provider of single cell technology, today launched a high throughput single nuclei RNA sequencing (sNuc-Seq) protocol for its Nadia Instrument. This latest addition to the Nadia application portfolio enables researchers to cost-effectively profile both complex and archived tissues.?
Dolomite Bio, a leading provider of high throughput single cell technology today announced the release of its new drop-seq datasets for single cell RNA-Seq.?The data, generated on Dolomite Bio’s Nadia Instrument, demonstrates excellent?single cell?RNA-seq performance with high gene capture, low doublet rates and cost-effective profiling.